Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Almirall's Enterprise Value is $2,768 Mil.
Almirall's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $122 Mil. Therefore, Almirall's EV-to-EBIT ratio for today is 22.70.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Almirall's Enterprise Value is $2,768 Mil.
Almirall's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $348 Mil. Therefore, Almirall's EV-to-EBITDA ratio for today is 7.95.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Almirall's Enterprise Value is $2,768 Mil.
Almirall's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $1,601 Mil. Therefore, Almirall's EV-to-Revenue ratio for today is 1.73.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Almirall's Enterprise Value is $2,768 Mil.
Almirall's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $58 Mil. Therefore, Almirall's EV-to-FCF ratio for today is 47.33.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Almirall (OTCPK:LBTSF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Almirall's current Enterprise Value is $2,768 Mil.
Almirall's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $122 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Almirall's current Enterprise Value is $2,768 Mil.
Almirall's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $348 Mil.
Almirall's current Enterprise Value is $2,768 Mil.
Almirall's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,601 Mil.
Almirall's current Enterprise Value is $2,768 Mil.
Almirall's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $228 Mil.
Almirall's current Enterprise Value is $2,768 Mil.
Almirall's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almirall Enterprise Value Related Terms
Almirall Enterprise Value Historical Data
* Premium members only.
The historical data trend for Almirall's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBTSF vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almirall Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Almirall's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Almirall's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Almirall's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almirall (LBTSF) has a Enterprise Value of $2,768 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Almirall and its competitors.
Is Almirall's Enterprise Value too high?
Almirall's current Enterprise Value is $2,768 Mil. Overall, Almirall has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Enterprise Value compare to ZTS and UTHR?
Almirall's Enterprise Value of $2,768 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Almirall and its competitors. Almirall's current Enterprise Value is $2,768 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Enterprise Value of $2,768 Mil. The stock's GF Value™ is $16.92, compared to a current price of $15.35 — trading 9.3% below its estimated fair value. The current Enterprise Value is $2,768 Mil. Almirall's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Almirall (LBTSF), the current Enterprise Value is $2,768 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Almirall (LBTSF) Overvalued in 2026?
Based on GuruFocus' analysis, Almirall stock appears to be undervalued.
The current stock price of $15.35 is trading 9.3% below its estimated GF Value™ of $16.92.
Key valuation signals for LBTSF:
Enterprise Value: $2,768 Mil
GF Value™: $16.92 vs. price of $15.35 (9.3% below fair value)
No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
85GF Score
Get the complete analysis for LBTSF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LBTSF has been successfully added to your 
